Research on theoretical prediction methods for the mixture toxicity of engineered
nanoparticles (ENPs) faces significant challenges. The application of in silico methods …

Schizophrenia is a chronic psychotic disorder characterized primarily by cognitive deficits.
Drugs and therapies are helpful in managing the symptoms, mostly with long-term …

Background Alzheimer's disease (AD), the most common cause of dementia in the elderly, is
a progressive neurodegenerative disorder that gradually affects cognitive function and …

Background The inhibition of dopamine transporter is known to play a significant role in the
treatment of schizophrenia-related and other mental disorders. In a continuing from our …

The drug discovery and development process requires a lot of time, financial, and workforce
resources. Any reduction in these burdens might benefit all stakeholders in the healthcare …

Due to the increasing emergences of drug resistance, there is a need to discover new drugs
that can target Schistosoma mansoni histone deacetylase 8 (SmHDAC8) and effectively …

Dopamine transporter inhibition is deemed a promising approach to treating schizophrenia.
This research paper outlines various QSAR models for molecules acting as dopamine …

The dopamine transporter (DAT), responsible for the regulation of dopaminergic
neurotransmission, is implicated in the etiology of several neuropsychiatric disorders which …

In furtherance to our previous study, in silico drug design and pharmacokinetics study were
employed on some arylpiperazine derivatives as inhibitors of serotonin transporter (SERT) …

Research on theoretical prediction methods for the mixture toxicity of engineered
nanoparticles (ENPs) faces significant challenges. The application of in silico methods …